Published: February 3rd 2025 | Updated: March 4th 2025
Ocugen, Inc. receives European Medicines Agency ATMP designation for new gene therapy OCU400
Published: January 13th 2025 | Updated: February 5th 2025
Teva partners with Klinge Biopharma, Lotus Pharmaceutical for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)
Published: January 31st 2024 | Updated: May 9th 2024
How biosimilars expand treatment options for patients with retinal disease
Published: January 23rd 2025 | Updated: May 6th 2025
EYLEA’s unique MoA: What is the rationale for the higher molar dose?
Published: February 13th 2025 | Updated: May 6th 2025
Veterinary ophthalmology can foster insights and progress in glaucoma care
Published: April 28th 2025 | Updated: May 6th 2025
Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting